Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJarvis Securities Regulatory News (JIM)

Share Price Information for Jarvis Securities (JIM)

Share Price is delayed by 15 minutes
Get Live Data
9.00    0.00 (0.00%)
Bid:
8.00
Ask:
10.00
Spread: 2.00 (25.00%)
Market Cap: £4.03m
JIM Live PriceLast checked at - London Stock Exchange

Intraday Jarvis Securities Share Chart

Board Change/Director Dealing

7 Feb 2008 09:41

Jarvis Securities plc07 February 2008 Jarvis Securities plc ("Jarvis" or "the Company") Board Change/Director's Shareholding/Transaction in Own Shares Jarvis Securities plc, the administration and outsourcing operation whichsupplies retail execution only stock broking facilities as well as outsourcedinvestment services and Model B settlement, is pleased to announce theappointment of Graeme McAusland B.Sc to the Board as a Non-Executive Directorwith effect from 1 March 2008. Graeme (aged 42) has held a number of senior positions and is on the Board ofThe Children's Mutual where he holds the post of Chief Operating Officerresponsible for all financial and governance areas including compliance, riskmanagement and audit functions. He has implemented and managed a number of newoperating and business models to enhance and increase the scale of business,having previously held the position of Financial Director and Appointed Actuary. Prior to this, Graeme held various management roles including Head of CorporateDevelopment with Prudential plc and is a Fellow of the Faculty of Actuaries. Graeme owns no shares or options in the Company at the present time. The following information is disclosed pursuant to Rule 17, Schedule Two (g) ofthe AIM Rules for Companies: Current Appointments Tunbridge Wells Insurance Services Limited Tunbridge Wells Equitable Investments Company Limited Tunbridge Wells Equitable Services Company Graeme is also a member of the Management Board of the Tunbridge Wells EquitableFriendly Society Limited There is no further information to disclose. Commenting on the appointment of Graeme to the Board, Andrew Grant, Chairman andChief Executive said: "We are delighted that Graeme has agreed to join the Board of Jarvis. He willbring his undoubted personal drive and expertise to enhance the Company'sstrategy and operations" John Mackay, who has been a non-Executive Director of the Company since 2004,has in view of his other business commitments agreed to stand down as anon-Executive Director effective from 29 February 2008. John has been veryhelpful to us over the last 3 years and we would like to thank him for hiscontribution to the Company's development and wish him well for the future. On 5 February, prior to John's departure, he exercised Options previouslygranted to him under the 2004 scheme pursuant to which he has acquired 50,000Ordinary Shares at a price of 82.5p per share. Following this purchase, John isbeneficially interested in 50,000 Ordinary Shares representing approximately 0.4per cent. of the Company's current issued share capital. The shares have beensatisfied from Treasury. The Company announces that between 1 February 2008 and 6 February 2008 itacquired 49,000 shares at an average price of 200.562p to be held in Treasury.Following these transactions and the sale of shares to Mr Mackay, the Companynow holds nil Ordinary Shares in Treasury and has 10,800,000 Ordinary Shares inissue. For further information: Jarvis Securities plcAndrew Grant, Chairman & CEO Tel: 0870 224 1111 Daniel Stewart & Company plcLindsay Mair/Tessa Smith Tel: 020 7776 6550 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Aug 20237:00 amRNSDividend Declaration & Trading Update
13th Jul 20237:00 amRNSHalf-year Report
4th Jul 20232:57 pmRNSCompany Update
3rd Jul 20235:06 pmRNSHolding(s) in Company
3rd Jul 20235:04 pmRNSHolding(s) in Company
3rd Jul 20235:00 pmRNSHolding(s) in Company
3rd Jul 20234:59 pmRNSHolding(s) in Company
16th Jun 20238:59 amRNSHolding(s) in Company
16th Jun 20238:57 amRNSHolding(s) in Company
16th Jun 20238:54 amRNSHolding(s) in Company
11th May 20232:04 pmRNSDividend Declaration
20th Apr 20231:24 pmRNSResult of AGM
31st Mar 20237:00 amRNSCompany Update
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20232:05 pmRNSSecond Price Monitoring Extn
9th Mar 20232:00 pmRNSPrice Monitoring Extension
9th Mar 20237:00 amRNSResults for year ended 31 December 2022
8th Feb 20233:20 pmRNSDividend Declaration
10th Nov 20222:01 pmRNSDividend Declaration
13th Oct 20227:00 amRNSDirector/PDMR Shareholding
11th Oct 20225:11 pmRNSDirector/PDMR Shareholding
20th Sep 20229:05 amRNSSecond Price Monitoring Extn
20th Sep 20229:00 amRNSPrice Monitoring Extension
16th Sep 20222:39 pmRNSCompany Update
9th Aug 20223:15 pmRNSDividend Declaration
14th Jul 20227:00 amRNSHalf-year report
10th May 20223:36 pmRNSDividend Declaration
21st Apr 202211:30 amRNSResult of AGM
10th Mar 20227:00 amRNSResults for year ended 31 December 2021
15th Feb 20221:54 pmRNSDividend Declaration
15th Feb 20221:13 pmRNSDividend Declaration
9th Nov 20211:43 pmRNSDividend Declaration
10th Aug 20211:50 pmRNSDividend Declaration
16th Jul 202112:24 pmRNSShare Premium Cancellation & Dividend Declaration
15th Jul 20217:00 amRNSHalf-year Report
29th Jun 202112:27 pmRNSCancellation of Share Premium - Court approved
23rd Jun 20217:00 amRNSCancellation of Share Premium - Update
11th Jun 20211:03 pmRNSCancellation of Share Premium Update
12th May 20217:00 amRNSDividend Declaration
4th May 202112:45 pmRNSResult of General Meeting
26th Apr 20212:49 pmRNSNotice regarding COVID-19 and the General Meeting
22nd Apr 202110:36 amRNSResult of AGM
8th Apr 20217:00 amRNSResult of PrimaryBid Offer
7th Apr 20214:54 pmRNSPrimaryBid Offer, Notice of GM & Capital Reduction
30th Mar 20217:00 amRNSBoard Changes
19th Mar 20212:30 pmRNSTransaction in Own Shares
11th Mar 20217:00 amRNSResults for year ended 31 December 2020
16th Feb 202112:11 pmRNSDividend Declaration
3rd Feb 20211:31 pmRNSHolding(s) in Company
11th Dec 202010:19 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.